Related Experiment Video
Updated: Apr 23, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
LiGen: a high performance workflow for chemistry driven de novo design
Andrea R Beccari1, Carlo Cavazzoni, Claudia Beato
1Dompé R&D Centre, Dompé SpA, Via Campo di Pile, 67100 L'Aquila, Italy. a.beccari@dompe.it
LiGen is a new software suite for molecular de novo design. It efficiently identifies novel chemical structures with desired biological properties using structure-based or ligand-based approaches.
Area of Science:
- Computational chemistry
- Drug discovery
- Cheminformatics
Background:
- Molecular de novo design tools are crucial for identifying novel chemical structures with specific biological properties.
- Existing methods often face challenges in efficiency and structural novelty.
Purpose of the Study:
- To present LiGen, a versatile suite of programs for molecular de novo design.
- To enable efficient identification of structurally new chemotypes with desired biological properties.
Main Methods:
- LiGen utilizes a combination of structure-based (active site identification) and ligand-based (pharmacophore definition) approaches.
- It features a pharmacophore-based docking procedure allowing flexible docking without conformer enumeration.
- Accurate reactant mapping and tagging via substructure searching are key functionalities.
Main Results:
- LiGen modules can be used sequentially or as stand-alone tools.
- The software supports user-defined workflows for project-centric applications.
- It facilitates the generation of novel chemical structures with predefined properties.
Conclusions:
- LiGen offers a flexible and efficient platform for molecular de novo design.
- Its unique features enhance the identification of novel chemotypes for drug discovery.
- The suite provides a comprehensive solution for computational chemists and drug designers.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026